Senseonics Holdings, INC Form 4 insider transactions

Senseonics Holdings, Inc. director Stephen P. DeFalco was granted 111,386 restricted stock units and 157,234 stock options as part of the company's non-employee director compensation policy.

Senseonics Holdings, Inc. Chief Medical Officer and Director Francine Kaufman was granted 455,716 restricted stock units and 642,911 employee stock options on May 23, 2025.

Senseonics Holdings, Inc. Director Edward Fiorentino was granted 111,386 Restricted Stock Units and 157,234 stock options as part of the company's non-employee director compensation policy.

Senseonics Holdings, Inc. Director Douglas A. Roeder was granted 111,386 restricted stock units and 157,234 stock options as part of the company's non-employee director compensation policy.

Senseonics Holdings, Inc. Chief Operating Officer Mukul Jain was granted 990,688 restricted stock units and 1,397,632 employee stock options, reinforcing executive retention and long-term alignment with company performance.

Senseonics Holdings, Inc. Chief Financial Officer Frederick T. Sullivan was granted 693,481 restricted stock units and 978,342 employee stock options on May 23, 2025, as part of his compensation.

Senseonics Holdings, Inc. CEO and Director Timothy T. Goodnow has been granted significant equity awards, including restricted stock units and employee stock options, aligning his interests with long-term shareholder value.

Frederick T. Sullivan, CFO of Senseonics Holdings, Inc., reports a transaction involving common stock to cover withholding tax obligations.

Francine Kaufman, Chief Medical Officer and Director at Senseonics Holdings, sold shares to cover withholding tax obligations upon the vesting of restricted stock units.

Mukul Jain, Chief Operating Officer of Senseonics Holdings, reports disposing of shares to cover withholding tax obligations upon the vesting of restricted stock units.

Kenneth L. Horton, GC & Corp. Development Advisor at Senseonics Holdings, Inc., disposed of shares to cover withholding tax obligations.

Senseonics Holdings CEO Timothy Goodnow disposed of shares to cover withholding tax obligations related to vesting restricted stock units.

Director Edward Fiorentino acquired 21,243 shares of Senseonics Holdings, Inc. common stock on April 1, 2025, in lieu of quarterly retainer fees.

Director Steven Edelman acquired 19,363 shares of Senseonics Holdings, Inc. common stock on April 1, 2025, in lieu of quarterly retainer fees.

Director Douglas S. Prince acquired 12,219 shares of Senseonics Holdings, Inc. common stock on April 1, 2025, in lieu of quarterly retainer fees.

Director Douglas A. Roeder acquired 22,183 shares of Senseonics Holdings, Inc. common stock on April 1, 2025, in lieu of quarterly retainer fees.

Senseonics Holdings director Douglas A. Roeder acquired 31,183 shares of common stock in lieu of quarterly retainer fees.

Senseonics Holdings director Edward Fiorentino acquired 29,862 shares of common stock in lieu of quarterly retainer fees.

Senseonics Holdings director Douglas S. Prince acquired 17,177 shares of common stock on January 2, 2025, in lieu of quarterly retainer fees.

Senseonics Holdings director Steven Edelman acquired 27,219 shares of common stock in lieu of quarterly retainer fees.

A Senseonics Holdings director, Douglas A. Roeder, amended a previous SEC filing to correct the number of shares purchased and beneficially owned after a transaction.

Senseonics Holdings director Douglas Roeder has acquired 325,000 shares of common stock in two transactions on December 12th and 13th, 2024.

Senseonics Holdings' Chief Financial Officer, Frederick T. Sullivan, purchased 124,933 shares of common stock in a series of transactions at prices ranging from $0.363 to $0.40.

Senseonics Holdings CEO, Timothy T. Goodnow, purchased 315,000 shares of common stock in the open market at a weighted average price of $0.31.

Senseonics Holdings' Chief Financial Officer, Frederick T. Sullivan, sold 181,627 shares of common stock to cover tax obligations related to vesting restricted stock units.

Senseonics Holdings' Chief Medical Officer, Francine Kaufman, sold 118,645 shares of common stock to cover tax obligations related to vesting restricted stock units.

Senseonics Holdings' Chief Operating Officer, Mukul Jain, sold 282,546 shares of common stock to cover tax obligations related to vesting restricted stock units.

Kenneth L. Horton, a Senseonics Holdings executive, sold 187,665 shares to cover tax obligations related to vesting restricted stock units.

Senseonics Holdings CEO, Timothy T. Goodnow, sold 632,166 shares of common stock to cover tax obligations related to vesting restricted stock units.

Director Steven Edelman acquired 38,193 shares of Senseonics Holdings, Inc. common stock on October 1, 2024, in lieu of quarterly retainer fees.